|
1
|
Suri A: Cancer testis antigens - their
importance in immuno-therapy and in the early detection of cancer.
Expert Opin Biol Ther. 6:379–389. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Kawakami Y: New cancer therapy by
immunomanipulation: Development of immunotherapy for human melanoma
as a model system. Cornea. 19(Suppl 3): S2–S6. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Caballero OL and Chen YT: Cancer/testis
(CT) antigens: Potential targets for immunotherapy. Cancer Sci.
100:2014–2021. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Garg M, Chaurasiya D, Rana R, Jagadish N,
Kanojia D, Dudha N, Kamran N, Salhan S, Bhatnagar A, Suri S, et al:
Sperm-associated antigen 9, a novel cancer testis antigen, is a
potential target for immunotherapy in epithelial ovarian cancer.
Clin Cancer Res. 13:1421–1428. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Garg M, Kanojia D, Khosla A, Dudha N, Sati
S, Chaurasiya D, Jagadish N, Seth A, Kumar R, Gupta S, et al:
Sperm-associated antigen 9 is associated with tumor growth,
migration, and invasion in renal cell carcinoma. Cancer Res.
68:8240–8248. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Kanojia D, Garg M, Gupta S, Gupta A and
Suri A: Sperm-associated antigen 9, a novel biomarker for early
detection of breast cancer. Cancer Epidemiol Biomarkers Prev.
18:630–639. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Garg M, Kanojia D, Salhan S, Suri S, Gupta
A, Lohiya NK and Suri A: Sperm-associated antigen 9 is a biomarker
for early cervical carcinoma. Cancer. 115:2671–2683. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Garg M, Kanojia D, Suri S, Gupta S, Gupta
A and Suri A: Sperm-associated antigen 9: A novel diagnostic marker
for thyroid cancer. J Clin Endocrinol Metab. 94:4613–4618. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Li H, Peng Y, Niu H, Wu B, Zhang Y, Zhang
Y, Bai X and He P: SPAG9 is overexpressed in human prostate cancer
and promotes cancer cell proliferation. Tumour Biol. 35:6949–6954.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Yi F, Ni W, Liu W, Pan X, Han X, Yang L,
Kong X, Ma R and Chang R: SPAG9 is overexpressed in human
astrocytoma and promotes cell proliferation and invasion. Tumour
Biol. 34:2849–2855. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Xie C, Fu L, Liu N and Li Q:
Overexpression of SPAG9 correlates with poor prognosis and tumor
progression in hepatocellular carcinoma. Tumour Biol. 35:7685–7691.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar
|
|
13
|
Hara A and Okayasu I: Cyclooxygenase-2 and
inducible nitric oxide synthase expression in human astrocytic
gliomas: Correlation with angiogenesis and prognostic significance.
Acta Neuropathol. 108:43–48. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Zhong L, Coe SP, Stromberg AJ, Khattar NH,
Jett JR and Hirschowitz EA: Profiling tumor-associated antibodies
for early detection of non-small cell lung cancer. J Thorac Oncol.
1:513–519. 2006. View Article : Google Scholar
|
|
15
|
Chapman CJ, Murray A, McElveen JE, Sahin
U, Luxemburger U, Türeci O, Wiewrodt R, Barnes AC and Robertson JF:
Auto-antibodies in lung cancer: Possibilities for early detection
and subsequent cure. Thorax. 63:228–233. 2008. View Article : Google Scholar
|
|
16
|
Qiu J, Choi G, Li L, Wang H, Pitteri SJ,
Pereira-Faca SR, Krasnoselsky AL, Randolph TW, Omenn GS, Edelstein
C, et al: Occurrence of autoantibodies to Annexin I, 14-3-3 theta
and LAMR1 in prediagnostic lung cancer sera. J Clin Oncol.
26:5060–5066. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Tan HT, Low J, Lim SG and Chung MC: Serum
autoantibodies as biomarkers for early cancer detection. FEBS J.
276:6880–6904. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Scanlan MJ, Simpson AJ and Old LJ: The
cancer/testis genes: Review, standardization, and commentary.
Cancer Immun. 4:12004.PubMed/NCBI
|
|
19
|
de Visser KE, Korets LV and Coussens LM:
De novo carcinogenesis promoted by chronic inflammation is B
lymphocyte dependent. Cancer Cell. 7:411–423. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Chen F, Lu Z, Deng J, Han X, Bai J, Liu Q,
Xi Y and Zheng J: SPAG9 expression is increased in human prostate
cancer and promotes cell motility, invasion and angiogenesis in
vitro. Oncol Rep. 32:2533–2540. 2014.PubMed/NCBI
|
|
21
|
Jiang J, Liu Y, Fang W and Liu F: Sperm
associated antigen 9 promotes astrocytoma cell invasion through the
upregulation of podocalyxin. Mol Med Rep. 10:417–422.
2014.PubMed/NCBI
|
|
22
|
Kanojia D, Garg M, Saini S, Agarwal S,
Parashar D, Jagadish N, Seth A, Bhatnagar A, Gupta A, Kumar R, et
al: Sperm associated antigen 9 plays an important role in bladder
transitional cell carcinoma. PLoS One. 8:e813482013. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Baser E, Togrul C, Ozgu E, Ayhan S, Caglar
M, Erkaya S and Gungor T: Sperm-associated antigen 9 is a promising
marker for early diagnosis of endometrial cancer. Asian Pac J
Cancer Prev. 14:7635–7638. 2013. View Article : Google Scholar
|
|
24
|
Wang Y, Dong Q, Miao Y, Fu L, Lin X and
Wang E: Clinical significance and biological roles of SPAG9
overexpression in non-small cell lung cancer. Lung Cancer.
81:266–272. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Qiu J and Hanash S: Autoantibody profiling
for cancer detection. Clin Lab Med. 29:31–46. 2009. View Article : Google Scholar : PubMed/NCBI
|
